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fenestration was 23.0  6.0 minutes. Meanwhile, the mean time for the
selection of the right carotid artery was 3.6 0.9minutes. There was no
major adverse event in the 6 pigs. Six pigs survived the 8-weeks
observational period. For FASGs with window shaped fenestration, no
endoleaks, no disconnection of the stent grafts, and no occlusion of the
stent grafts for the carotid arteries were observed in the DSA at 4weeks.
Moreover, no disconnection or tearing of the stent grafts, no fractures in
the stent grafts, and no occlusion of the stent graft for carotid arteries
were found in the postmortem gross ﬁndings.
CONCLUSION The window shape FASG with the preloaded catheter
developed for emergencywas found to be safe and convenient to use in this
preclinical studywith swine. Readymadewindow shape FASGswhich have
several sized fenestrated window can be applied in case of emergency.
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BACKGROUND Although it is well known that the chronic kidney
disease (CKD) is a key factor for CIN, the effective therapy for the
prevention of CIN especially in advanced CKD-Patients has not been
established so far. Recently, it was reported that continuous hemo-
ﬁltration (CHF) could prevent CIN and reduce in-hospital mortality in
advanced CKD-patients via both ﬁltrating contrast and administration
of alkaline agents. However, this method requires a long duration-
time (18 to 30 hours) because of its low removal efﬁciency. Applying
this principle, we established a novel continuous hemodiaﬁltration
(CHDF) technique to get more effective blood clariﬁcation which
promotes replacement and dialysate ﬂow up to 5 times compared to
standard CHDF. By using this method we demonstrated that the
required time for 99 % removal of contrast could be shorten to one
sixth (about 4.5 hours) in our vitro experiment and named this pro-
cedure as High-ﬂow CHDF (HF-CHDF). In this report, we performed
HF-CHDF in clinical application for advanced CKD-Patients required
intervention.
METHODS We retrospectively analyzed the incidence of CIN in
consecutive 43 advanced CKD patients (8 in stage3b, 33 in stage4, and
2 in stage5) from Jan. 2009 to Dec. 2013. In addition of 0.9 % saline
hydration, HF-CHDF was performed from just before the procedure
until 2.5 hours after intervention in all patients. We deﬁned CIN as
sCre increase over 25 % from the baseline value at the point of 1 month
after intervention.
RESULTS At baseline, mean serum creatinine (sCre) was 2.31  0.62
mg/dl, and mean eGFR was 24.0  6.5 ml/min/1.73m2. And, sCre was
2.29  0.79 mg/dl, eGFR 25.6  9.6 ml/min/1.73m2 at 1 month after
procedure. The incidence of CIN was 4.6% (2 in 43), which was
remarkably lower than previous reports (the incidence of CIN by
hydration only was 15-20%, by alkaline agents was 10-15%). Rate of
occurrence requiring permanent HD due to CIN within 1year was
2.3%.CONCLUSION HF-CHDF method during and after PCI and PPI proce-
dure which we have established could be new standard for preventing
CIN in advanced CKD-patients required intervention.
Following this pilot study, multi-center trial is now ongoing to
construct further evidence in Japan.INVASIVE CORONARY IMAGING: IVUS, OCT,
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BACKGROUND Approximately 30% of stents implanted into saphe-
nous vein grafts (SVG) fail at 3-years follow-up. Although the pa-
thology of in stent restenosis (ISR) in SVG was presented by autopsy
study, there are just few reports using invasive imaging.
METHODS The report presents optical coherence imaging (OCT) im-
aging of ISR in SVG from 8 cases [in total 168 mm of ISR morphology]
enrolled into OCTOPUS Registry. The mean time from implantation
was 3123 months.
RESULTS The report presents optical coherence imaging (OCT) im-
aging of ISR in SVG from 8 cases [in total 168 mm of ISR morphology]
enrolled into OCTOPUS Registry. The mean time from implantation
was 3123 months.
Figure. The summary graph of in-stent neointima composition of ISR in SVG
The ﬁgure represents neoinitma composition in every 1mm in restenosis BMS and DES implanted into
the SVG. A one circle and a one box indicate a 1mm of BMS and DES respectively
CONCLUSION Patterns of in-stent neointima of SVG ISR were shown:
ﬁbrotic, lipid, heterogeneous, and calciﬁed. Heterogeneous pattern
seems to develop earlier in DES vs. BMS.
